| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 09/14/2005 | EP1363651B1 Herbal compositions useful as chemopreventive and therapeutic agents |
| 09/14/2005 | EP1296700B1 Anti-carcinogenic activity of hydroxylated chalcone compounds extracted from licorice root |
| 09/14/2005 | EP1284958B1 Method of inhibiting amyloid protein aggregation and imaging amyloid deposits using aminoidane derivatives |
| 09/14/2005 | EP1283825B1 N-substituted peptidyl nitriles as cysteine cathepsin inhibitors |
| 09/14/2005 | EP1274446B1 Polysaccharidic esters of n-derivatives of glutamic acid |
| 09/14/2005 | EP1274445B1 Use of steroidal alkaloids to reverse multidrug resistance |
| 09/14/2005 | EP1250317B1 Bis-basic compounds for use as tryptase inhibitors, method for producing the same and their use as medicaments |
| 09/14/2005 | EP1210335B1 Aminocarbonyl-substituted benzimidazole derivatives, method for producing same and the use thereof as medicaments |
| 09/14/2005 | EP1171127B1 Pharmaceutical compositions containing pyridine or pyrimidine derivatives for inhibition of cytokine production and secretion |
| 09/14/2005 | EP1137422B1 Use of human prostate cell lines for the treatment of prostate cancer |
| 09/14/2005 | EP1092028B1 Specific binding proteins including antibodies which bind to the necrotic centre of tumours, and uses thereof |
| 09/14/2005 | EP1082141B1 Cd40 binding antibodies and ctl peptides for treating tumors |
| 09/14/2005 | EP1071420B1 Indolyl-3-glyoxylic acid derivatives with antitumoral activity |
| 09/14/2005 | CN1668755A Galactosyl isomalt, method for production and use thereof |
| 09/14/2005 | CN1668750A Her-2/neu DNA vaccine having anti-cancer activity |
| 09/14/2005 | CN1668746A MUC-1 antigen with reduced number of VNTR repeat units |
| 09/14/2005 | CN1668741A Production of polyketides and other natural products |
| 09/14/2005 | CN1668733A Methods of using JNK or MKK inhibitors to modulate cell differentiation and to treat myeloproliferative disorders and myelodysplastic syndromes |
| 09/14/2005 | CN1668644A Selected antibodies and duramycin peptides binding to anionic phospholipids and aminophospholipids and their use in treating viral infections and cancer |
| 09/14/2005 | CN1668628A Novel thiophene glycoside derivatives, processes for the preparation, medicaments comprising these compounds, and the use thereof |
| 09/14/2005 | CN1668619A Imidazo[1, 2-a]pyrazin-8-ylamines, method of making and method of use thereof |
| 09/14/2005 | CN1668614A Bicyclic piperidine derivatives as antagonists of the CCR1 chemokine receptor |
| 09/14/2005 | CN1668613A Flavone derivatives of inhibitors of cyclin-dependent kinases |
| 09/14/2005 | CN1668609A Substituted 4-aryl-4H-pyrrolo[2, 3-H]chromenes and analogs as activators of caspases and inducers of apoptosis and the use thereof |
| 09/14/2005 | CN1668604A Novel anthracene derivatives and the use thereof as a medicament |
| 09/14/2005 | CN1668601A N-substituted tricyclic 3-aminopyrazoles as PDFG receptor inhibitors |
| 09/14/2005 | CN1668592A Piperidine derivatives and their use as selective inhibitors of MIP-1alpha binding to its receptor CCR1 |
| 09/14/2005 | CN1668589A Indoline derivatives substituted in the 6 position, their preparation and their use as medicaments |
| 09/14/2005 | CN1668588A Indole derivatives, method for preparing same and pharmaceutical compositions containing same |
| 09/14/2005 | CN1668583A Retinol derivatives, their use in the treatment of cancer and for potentiating the efficacy of other cytotoxic agents |
| 09/14/2005 | CN1668579A Benzamide or phenylacetamide derivatives useful as thyroid receptor ligands |
| 09/14/2005 | CN1668561A Remedy |
| 09/14/2005 | CN1668339A Steroid conjugates, preparation thereof and the use thereof |
| 09/14/2005 | CN1668336A Drug transport and delivery system |
| 09/14/2005 | CN1668335A Drug pre-targeting by means of bi-specific antibodies and hapten constructs comprising a carrier peptide and the active agent(s) |
| 09/14/2005 | CN1668333A Stable pharmaceutical composition comprising erythropoietin |
| 09/14/2005 | CN1668326A Intratumorally administered lactoferrin in the treatment of malignant neoplasms and other hyperproliferative diseases |
| 09/14/2005 | CN1668325A Lactoferrin in the treatment of malignant neoplasms and other hyperproliferative diseases |
| 09/14/2005 | CN1668323A Covalent conjugates between artemisinin-related endoperoxides and iron-carrying proteins and methods of use |
| 09/14/2005 | CN1668306A 4-4(methylpiperazin-1-ylmethyl)-n-[4-methyl-3-((pyridin-3-yl)pyrimidin-2-ylamino)phenyl]-benzamide for treating mutated-RET kinase associated diseases |
| 09/14/2005 | CN1668304A Crystalline 2, 5-dione-3-(1-methyl-1h-indol-3-yl)-4-[1-(pyridin-2-ylmethyl)piperidin-4-yl]-1h-indol-3-yl]-1h-pyrrole mono-hydrochloride |
| 09/14/2005 | CN1668299A Methods for using JNK inhibitors for treating or preventing disease-related wasting |
| 09/14/2005 | CN1668298A Antitumor compound and therapeutic uses thereof |
| 09/14/2005 | CN1668296A Methods and compositions using selective cytokine inhibitory drugs for treatment and management of cancers and other diseases |
| 09/14/2005 | CN1668293A Methods of using artemisinin-like compounds to prevent or delay the appearance of cancer |
| 09/14/2005 | CN1668285A Lasofoxifene tablet and its coating |
| 09/14/2005 | CN1667124A Recombinant adenovirus and its application in malignant tumor treatment |
| 09/14/2005 | CN1666997A Fusion protein, gene encoding same, and use thereof |
| 09/14/2005 | CN1666985A Medical use of andrographolidume and its derivatives and analogs |
| 09/14/2005 | CN1666982A Mixtures and compounds from Antrodia camphorate myceliums and use thereof |
| 09/14/2005 | CN1666780A Method for degrading AML 1-ETO fusion protein and used reagent |
| 09/14/2005 | CN1666776A Ganoderma lucidum and seabuckthorn fruit-containing capsule |
| 09/14/2005 | CN1666770A Chinese medicine for treating liver cancer and ascites caused thereby |
| 09/14/2005 | CN1666766A Anticancer Chinese medicinal injection and its preparation method |
| 09/14/2005 | CN1666753A Populus plant bud or bud scale extract with anticancer activity |
| 09/14/2005 | CN1666752A Medicine for blood generation and preparing method thereof |
| 09/14/2005 | CN1666747A Fructose injection of anti-tumor drug |
| 09/14/2005 | CN1666742A Combination therapy to treat hepatitis b virus |
| 09/14/2005 | CN1666738A Medicine for treating M2 type acute myelogenous leukemia and preparation method of injection thereof |
| 09/14/2005 | CN1219055C A specific proliferation in tumour cell which can express antioncogene with high efficiency and the use of it |
| 09/14/2005 | CN1219054C Structure for recombinant adenovirus with double killer function and application in tumor treatment |
| 09/14/2005 | CN1218983C Folic acid-polydiol compound and its medicinal composition |
| 09/14/2005 | CN1218955C Pregnanedione compound, preparation method and use |
| 09/14/2005 | CN1218936C Carboxamide-substituted phenylurea derivatives, process for their preparation and their use as medicaments |
| 09/14/2005 | CN1218882C Ferric oxide with high magnetic-hysteresis heat generation ability for the use of tumour thermomagnetic therapy and method for preparing the same |
| 09/14/2005 | CN1218727C Traditional Chinese medicine composition for cancer |
| 09/13/2005 | US6943246 3′terminal sequence of hepatitis C virus genome and diagnostic and therapeutic uses thereof |
| 09/13/2005 | US6943194 oxidizing 3-(tert-butyl dimethylsilyl)oxy-4-methoxybenzaldehyde with potassium permanganate to form carboxylic acid, converting to corresponding acid chloride, protecting with a butyllithium derivative, deprotecting to form phenstatin |
| 09/13/2005 | US6943192 Treatment regimen for administration of phenylacetylglutamine, phenylacetylisoglutamine, and/or phenylacetate |
| 09/13/2005 | US6943191 dihydroxy or diketoaromatic compounds; protein kinase inhibitors; antiproliferative activity |
| 09/13/2005 | US6943188 For manufacture of medicament for use in treating asthma, multiple sclerosis, inflammatory disease |
| 09/13/2005 | US6943185 Use of 2-methyl-thiazolidine-2,4-dicarboxylic acid and/or physiologically compatible salts thereof for producing a medicament for treating cancers |
| 09/13/2005 | US6943183 Antiproliferative agnets; anticancer agents; skin disorders; restenosis |
| 09/13/2005 | US6943181 Use of substituted gamma-lactone compounds as pharmaceutical preparations |
| 09/13/2005 | US6943179 Biurethane derivatives |
| 09/13/2005 | US6943174 6,5-Fused bicyclic heterocycles |
| 09/13/2005 | US6943172 Antitumor agents; anticancer agents; sexual disorders; cardiovascular disorders |
| 09/13/2005 | US6943171 For therapy of urological, vascular or pulmonary disorders |
| 09/13/2005 | US6943158 for treating a fibroblast growth factor receptors (FGFR) kinase mediated disorder such as atherosclerosis |
| 09/13/2005 | US6943156 3-(5,6,7,8-Tetrahydro-(1,8)naphthyridin-2-yl)-ethoxy)-11H-di-b enzo(1,4)oxazepin-10-yl)-acetic acid; inhibiting bone resorption; vascular restenosis; osteoporosis; angiogenesis inhibitors; diabetic retinopathy; anticarcinogenic agents |
| 09/13/2005 | US6943151 Method of inhibiting bone resorption and/or promoting bone formation using GLP-2 and related compounds |
| 09/13/2005 | US6943150 Antiapoptosis polypeptides or fusion proteins coded by nucleic acids |
| 09/13/2005 | US6943026 A mixture of first and second nucleic acid constructs, is used for gene therapy, as antitumor agents, antiproliferative agents, suppressed by a wild-type p53 allele in non-tumour cells relative to tumor cells, prodrug activating thymidine kinase |
| 09/13/2005 | US6943016 incubating a mixture of astrocytes and glial cells from patient surgical resection, culturing, astrocytes joining to the culture vessel, removing the un-attached cells; purification; treating CNS trauma, neurodegenerative disorders |
| 09/13/2005 | US6943013 DNA expression vector; host cell transformed, transfected or infected with the vector; transgenic cell, tissue or organism; HCDS1 protein |
| 09/13/2005 | US6942992 Nucleic acid sequences encoding human slit-, megf-, and roundabout-like polypeptides |
| 09/13/2005 | US6942983 An isolated monoclonal antibody is used for binding and detecting a polypeptide having amino acid sequence with valine at residue 835, modulate kinase activity in cells, protein kinase C |
| 09/13/2005 | CA2426703C Therapeutic agents and methods of use thereof for the modulation of angiogenesis |
| 09/13/2005 | CA2279276C Arylsulfonylamino hydroxamic acid derivatives |
| 09/13/2005 | CA2231105C Farnesyl protein transferase inhibiting (imidazol-5-yl)methyl-2-quinolinone derivatives |
| 09/12/2005 | CA2460861A1 Combination of transplantation and oncolytic virus treatment |
| 09/09/2005 | WO2005083124A1 Antisense oligonucleotide modulation of stat3 expression |
| 09/09/2005 | WO2005083076A1 Immune stimulant oligonucleotide inducing interferon alpha |
| 09/09/2005 | WO2005083075A1 Novel gene participating in epidermal differentiation and use thereof |
| 09/09/2005 | WO2005083074A1 Tumor antigen peptides |
| 09/09/2005 | WO2005083064A1 Cancerous disease modifying antibodies |
| 09/09/2005 | WO2005083063A1 Cancerous disease modifying antibodies |
| 09/09/2005 | WO2005083062A1 Cell vaccine |
| 09/09/2005 | WO2005082924A1 23-hetero-analogs of ornithogalum caudatum saponin osw-1, the preparation and use thereof |
| 09/09/2005 | WO2005082921A1 Method for inhibiting cellular proliferation |